Skip to main content
. 2020 May 1;2020(5):CD008649. doi: 10.1002/14651858.CD008649.pub4

5.1. Analysis.

5.1

Comparison 5: Mannitol plus dornase alfa versus dornase alfa ‐ cross‐over study of individuals with cystic fibrosis, Outcome 1: FEV1 (% change from baseline)